Centrally Reduced Diffusion Sign for Differentiation between Treatment-Related Lesions and Glioma Progression: A Validation Study

被引:8
作者
Alcaide-Leon, P. [1 ]
Cluceru, J. [2 ]
Lupo, J. M. [2 ]
Yu, T. J. [2 ]
Luks, T. L. [2 ]
Tihan, T. [3 ]
Bush, N. A. [4 ]
Villanueva-Meyer, J. E. [2 ]
机构
[1] Univ Hlth Network, Dept Med Imaging, Toronto, ON, Canada
[2] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, 505 Parnassus L-352, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA
关键词
HIGH-GRADE GLIOMAS; TUMOR RECURRENCE; DIAGNOSTIC-ACCURACY; PSEUDOPROGRESSION; AGREEMENT; TENSOR; MRI; RADIOTHERAPY; TEMOZOLOMIDE; COEFFICIENT;
D O I
10.3174/ajnr.A6843
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Images of 231 patients who underwent an operation for suspected glioma recurrence were reviewed. Patients with susceptibility artifacts or without central necrosis were excluded. The final diagnosis was established according to histopathology reports. Two neuroradiologists classified the diffusion patterns on preoperative MR imaging as the following: 1) reduced diffusion in the solid component only, 2) reduced diffusion mainly in the solid component, 3) no reduced diffusion, 4) reduced diffusion mainly in the central necrosis, and 5) reduced diffusion in the central necrosis only. A total of 103 patients were included (22 with treatment-related lesions and 81 with tumor progression). The diagnostic accuracy results for the centrally reduced diffusion pattern as a predictor of treatment-related lesions ("mainly central" and "exclusively central" patterns versus all other patterns) were: 64% sensitivity, 84% specificity, 52% positive predictive value, and 89% negative predictive value. BACKGROUND AND PURPOSE: Differentiating between treatment-related lesions and tumor progression remains one of the greatest dilemmas in neuro-oncology. Diffusion MR imaging characteristics may provide useful information to help make this distinction. The aim of the study was to assess the diagnostic accuracy of the centrally reduced diffusion sign for differentiation of treatment-related lesions and true tumor progression in patients with suspected glioma recurrence. MATERIALS AND METHODS: The images of 231 patients who underwent an operation for suspected glioma recurrence were reviewed. Patients with susceptibility artifacts or without central necrosis were excluded. The final diagnosis was established according to histopathology reports. Two neuroradiologists classified the diffusion patterns on preoperative MR imaging as the following: 1) reduced diffusion in the solid component only, 2) reduced diffusion mainly in the solid component, 3) no reduced diffusion, 4) reduced diffusion mainly in the central necrosis, and 5) reduced diffusion in the central necrosis only. Diagnostic accuracy metrics and the area under the receiver operating characteristic curve were estimated for the diffusion patterns. RESULTS: One hundred three patients were included (22 with treatment-related lesions and 81 with tumor progression). The diagnostic accuracy results for the centrally reduced diffusion pattern as a predictor of treatment-related lesions ("mainly central" and "exclusively central" patterns versus all other patterns) were as follows: 64% sensitivity (95% CI, 41%-83%), 84% specificity (95% CI, 74%-91%), 52% positive predictive value (95% CI, 37%-66%), and 89% negative predictive value (95% CI, 83%-94%). CONCLUSIONS: The centrally reduced diffusion sign is associated with the presence of treatment effect. The probability of a histologic diagnosis of a treatment-related lesion is low (11%) in the absence of centrally reduced diffusion.
引用
收藏
页码:2049 / 2054
页数:6
相关论文
共 18 条
[1]   Treatment-induced lesions in newly diagnosed glioblastoma patients undergoing chemoradiotherapy and heat-shock protein vaccine therapy [J].
Alcaide-Leon, Paula ;
Luks, Tracy L. ;
Lafontaine, Marisa ;
Lupo, Janine M. ;
Okada, Hideho ;
Clarke, Jennifer L. ;
Villanueva-Meyer, Javier E. .
JOURNAL OF NEURO-ONCOLOGY, 2020, 146 (01) :71-78
[2]   Comparison of diffusion tensor, dynamic susceptibility contrast MRI and 99mTc-Tetrofosmin brain SPECT for the detection of recurrent high-grade glioma [J].
Alexiou, George A. ;
Zikou, Anastasia ;
Tsiouris, Spyridon ;
Goussia, Anna ;
Kosta, Paraskevi ;
Papadopoulos, Athanasios ;
Voulgaris, Spyridon ;
Tsekeris, Pericles ;
Kyritsis, Athanasios P. ;
Fotopoulos, Andreas D. ;
Argyropoulou, Maria I. .
MAGNETIC RESONANCE IMAGING, 2014, 32 (07) :854-859
[3]  
Asao C, 2005, AM J NEURORADIOL, V26, P1455
[4]  
Atlas SW, 2000, AM J NEURORADIOL, V21, P1190
[5]  
Bobek-Billewicz B, 2010, FOLIA NEUROPATHOL, V48, P81
[6]   Parametric Response Mapping of Apparent Diffusion Coefficient as an Imaging Biomarker to Distinguish Pseudoprogression from True Tumor Progression in Peptide-Based Vaccine Therapy for Pediatric Diffuse Intrinsic Pontine Glioma [J].
Ceschin, R. ;
Kurland, B. F. ;
Abberbock, S. R. ;
Ellingson, B. M. ;
Okada, H. ;
Jakacki, R. I. ;
Pollack, I. F. ;
Panigrahy, A. .
AMERICAN JOURNAL OF NEURORADIOLOGY, 2015, 36 (11) :2170-2176
[8]   A COEFFICIENT OF AGREEMENT FOR NOMINAL SCALES [J].
COHEN, J .
EDUCATIONAL AND PSYCHOLOGICAL MEASUREMENT, 1960, 20 (01) :37-46
[9]  
Hein PA, 2004, AM J NEURORADIOL, V25, P201
[10]   MEASUREMENT OF OBSERVER AGREEMENT FOR CATEGORICAL DATA [J].
LANDIS, JR ;
KOCH, GG .
BIOMETRICS, 1977, 33 (01) :159-174